Pioneering Health Technology Company
| Asking Price: | $500,000 |
| Gross Revenue: | $558,954 |
| Rent: | $2,700/Month |
| Established Year: | 2011 |
| Cash Flow: | $70,697 |
| Inventory: | $350,000 |
| FF&E: | $20,000 |
This pioneering health technology company specializes in the development and sale of non-invasive magnetic resonance therapy devices. These devices are designed to address Chronic Stress and its primary symptoms of Pain, Inflammation, Lack of Energy, Digestion, Sleep and promote natural healing processes, offering an innovative solution without the use of pharmaceuticals.
Key Highlights
1. Leading Technology:
• The company utilizes cutting-edge magnetic resonance technology, and SaaS (Software as a Service) business model which is at the forefront of non-invasive health therapies.
• The devices are designed to address stress and pain, providing a holistic alternative to traditional pharmaceutical treatments.
2. Market Potential:
• The health and wellness sector is rapidly expanding, and this company is well-positioned within this growth market.
• It has established a strong customer base, indicating robust demand and customer satisfaction.
• There are significant opportunities for global expansion, tapping into international markets that are increasingly embracing wellness technologies.
3. Investment Appeal:
• This business represents a lucrative investment opportunity for those looking to enter or expand in the health tech industry.
• The products align with modern health trends that favor natural and non-invasive treatment options.
• With a proven product ready for scaling, the business is poised for significant growth and increased market penetration.
• An (SaaS) based business that currently has $30,000/mth of recurring revenue
Sale Details
• Transition Support: The seller is committed to assisting with the transition, ensuring a smooth handover and continuity of operations.
• Inventory: The sale includes $350,000 worth of sellable inventory at cost, providing immediate value and reducing initial capital outlay for the buyer.
• Royalty Fee: An Exclusive Worldwide License for this technology, and access to a substantial Patent portfolio requires the Buyer to pay a 3% royalty fee on sales, which is already reflected in the current financials.
Confidentiality
This sale is being conducted discreetly. Detailed information will be provided upon verification of the buyer’s intent and financial capability, ensuring that only serious and qualified parties proceed.
This business presents a unique opportunity to acquire a company at the intersection of health technology and holistic wellness, with significant growth potential and a supportive transition plan from the current owner.
